Steve Schonfeld’s Cerenome CNSY Stock Holding History

Steve Schonfeld’s Portfolio CNSY Stock Details CNSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-508	Closed	-$60.4K	–	2534
2022 Q4	$60.4K	Buy	+508	New	+$80.9K	﹤0.01%	2247

Other funds holding CNSY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GVAG

Great Valley Advisor Group Wilmington, Delaware $6.33B AUM 25.27% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Steve Schonfeld's CNSY Position: Q1 2023 in Review

Steve Schonfeld sold out of Cerenome (CNSY) in Q1 2023, closing a stake of 508 shares — an estimated $60.4K sold.

Steve Schonfeld first reported a position in CNSY in Q4 2022 and held it in 1 quarter. The position peaked at $60.4K in Q4 2022. 16 funds tracked by Wall St. Rank hold CNSY as of Q1 2023.

Steve Schonfeld reported no remaining Cerenome position as of Q1 2023 after selling out during the quarter.
Steve Schonfeld sold 508 Cerenome shares in Q1 2023, an estimated $60.4K.
Steve Schonfeld first reported a position in Cerenome in Q4 2022 and held it in 1 quarter.
Steve Schonfeld's Cerenome position peaked at $60.4K in Q4 2022.
16 funds tracked by Wall St. Rank held Cerenome as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.